المؤلفون: James F. Donohue, Edward Kerwin, Chris N. Barnes, Edmund J. Moran, Brett Haumann, Glenn D. Crater

المصدر: BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-10 (2020)

مصطلحات موضوعية: COPD, Efficacy, Long-acting muscarinic antagonist, Nebulized therapy, Revefenacin, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

العلاقة: http://link.springer.com/article/10.1186/s12890-020-1156-4Test; https://doaj.org/toc/1471-2466Test

الوصول الحر: https://doaj.org/article/a02dc5fee0344cab954ec9e187b55225Test

المؤلفون: Borin MT, Lo A, Barnes CN, Pendyala S, Bourdet DL

المصدر: International Journal of COPD, Vol Volume 14, Pp 2305-2318 (2019)

مصطلحات موضوعية: Liver disease, kidney disease, chronic obstructive pulmonary disease, long-acting muscarinic antagonist, LAMA, revefenacin, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/pharmacokinetics-and-safety-ofTest-revefenacin-in-subjects-with-impaired-r-peer-reviewed-article-COPD; https://doaj.org/toc/1178-2005Test

الوصول الحر: https://doaj.org/article/f0cc79f3ebab44ef919b096244b0e6f9Test

المؤلفون: Jiaxing Zhang, Yihong Xie, Joey Sum-wing Kwong, Long Ge, Rui He, Wenyi Zheng, Jing Han, Rui Zhang, Huaye Zhao, Yuru He, Xiaosi Li

المصدر: Frontiers in Pharmacology, Vol 12 (2021)

مصطلحات موضوعية: chronic obstructive pulmonary disease, long-acting muscarinic antagonist, systematic review, dose-response meta-analysis, revefenacin, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fphar.2021.667027/fullTest; https://doaj.org/toc/1663-9812Test

الوصول الحر: https://doaj.org/article/29524f9f0acc43e79a6cd969fb35b56fTest

المؤلفون: Anca Zanfirescu, Georgiana Nitulescu, Dragos Paul Mihai, George Mihai Nitulescu

المصدر: Pharmaceuticals; Volume 15; Issue 1; Pages: 38

مصطلحات موضوعية: endocannabinoids, chronic pain, N-arachidonoylethanolamide, fatty acid amide hydrolase, drug repurposing, montelukast, repaglinide, revefenacin

وصف الملف: application/pdf

العلاقة: Medicinal Chemistry; https://dx.doi.org/10.3390/ph15010038Test

الإتاحة: https://doi.org/10.3390/ph15010038Test

المؤلفون: Bernardini, Claudio, Lang, Jacob, Kim, Jina, Kousta, Marina, Jackson, Audrey

المصدر: Journal of Health Policy and Economics; Vol. 1 No. 1 (2021): Inaugural Issue - ST 2021 ; 2732-4729

مصطلحات موضوعية: COPD, Revefenacin, Meta-analysis, Respiratory, Lungs, Pharmaceutical, Long-acting-muscarinic antagonist

وصف الملف: application/pdf; text/html

العلاقة: https://account.johpec.lse.ac.uk/index.php/lse-j-jhpe/article/view/24/36Test; https://account.johpec.lse.ac.uk/index.php/lse-j-jhpe/article/view/24/50Test; https://account.johpec.lse.ac.uk/index.php/lse-j-jhpe/article/view/24Test

الإتاحة: https://account.johpec.lse.ac.uk/index.php/lse-j-jhpe/article/view/24Test

المؤلفون: Quinn, Dean, Barnes, Christopher N., Yates, Wayne, Bourdet, David L., Moran, Edmund J., Potgieter, Peter, Nicholls, Andrew, Haumann, Brett, Singh, Dave

المصدر: Quinn , D , Barnes , C N , Yates , W , Bourdet , D L , Moran , E J , Potgieter , P , Nicholls , A , Haumann , B & Singh , D 2018 , ' Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD) : Results of two randomized, double-blind, phase 2 studies ' , Pulmonary Pharmacology and Therapeutics , vol. 48 , pp. 71-79 . https://doi.org/10.1016/j.pupt.2017.10.003Test

مصطلحات موضوعية: Anti-muscarinic, Bronchodilator, COPD, Inhalation, Long-acting muscarinic antagonist, Nebulized, Once-daily, Rapid onset, Revefenacin

الإتاحة: https://doi.org/10.1016/j.pupt.2017.10.003Test
https://research.manchester.ac.uk/en/publications/186818a6-fd55-4850-9346-f4a33f6534f4Test
http://www.scopus.com/inward/record.url?scp=85032826116&partnerID=8YFLogxKTest

المؤلفون: Gary T. Ferguson, David A. Lombardi, Krishna Pudi, Jill A. Ohar, Roslyn F. Schneider, Gregory Feldman

المصدر: Chest. 160:A1777-A1779

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Clinical trial, medicine.medical_specialty, business.industry, Internal medicine, medicine, In patient, Severe copd, Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine, business, Revefenacin

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e1f99942c7facb3fe4921813029d6563Test
https://doi.org/10.1016/j.chest.2021.07.1617Test

المؤلفون: Ruxandra Rajnoveanu, Mihaela Grigore, Sabina A Antoniu, Ruxandra Ulmeanu, Florin Mihaltan

المصدر: Expert Opinion on Pharmacotherapy. 21:997-1004

مصطلحات موضوعية: medicine.medical_specialty, Pulmonary disease, Muscarinic Antagonists, Disease, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Humans, Medicine, Pharmacology (medical), Pharmacology, COPD, Antimuscarinic Agent, biology, business.industry, General Medicine, Lama, biology.organism_classification, medicine.disease, Revefenacin, 030220 oncology & carcinogenesis, Benzamides, Carbamates, business, 030217 neurology & neurosurgery

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bb402c5fd45450e70f083fbb8acdc44Test
https://doi.org/10.1080/14656566.2020.1745185Test

المؤلفون: Akram Khan, Chitra Lal

المصدر: COPD

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Muscarinic Antagonists, Drug Administration Schedule, Article, Medication Adherence, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Quality of life (healthcare), Forced Expiratory Volume, medicine, Humans, 030212 general & internal medicine, Intensive care medicine, Lung function, Cause of death, COPD, business.industry, Nebulizers and Vaporizers, Inhaler, Public health, medicine.disease, Revefenacin, respiratory tract diseases, Clinical trial, Treatment Outcome, 030228 respiratory system, Benzamides, Carbamates, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed56e17d6c9a316b801fadd6f0b5ae3Test
https://doi.org/10.1080/15412555.2019.1702010Test

المؤلفون: Jing Han, Joey Sum-Wing Kwong, Wenyi Zheng, Long Ge, Jiaxing Zhang, Xiaosi Li, Rui He, Xie Yihong, Rui Zhang, Huaye Zhao, He Yuru

المصدر: Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)

مصطلحات موضوعية: dose-response meta-analysis, medicine.medical_specialty, RM1-950, Cochrane Library, Placebo, chronic obstructive pulmonary disease, law.invention, Randomized controlled trial, law, Internal medicine, medicine, long-acting muscarinic antagonist, Pharmacology (medical), Adverse effect, Pharmacology, COPD, biology, business.industry, Lama, medicine.disease, biology.organism_classification, Clinical trial, revefenacin, Ipratropium, Therapeutics. Pharmacology, Systematic Review, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c39d103e23db08e9aeba82a476be4b8Test
https://doi.org/10.3389/fphar.2021.667027Test